Norway
· Delayed Price · Currency is NOK Arctic Bioscience AS Statistics
Total Valuation
Arctic Bioscience AS has a market cap or net worth of NOK 342.49 million. The enterprise value is 264.94 million.
| Market Cap | 342.49M |
| Enterprise Value | 264.94M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
| Earnings Date | Aug 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Arctic Bioscience AS has 25.37 million shares outstanding. The number of shares has increased by 3.88% in one year.
| Shares Outstanding | 25.37M |
| Shares Change (YoY) | +3.88% |
| Shares Change (QoQ) | -0.66% |
| Owned by Insiders (%) | 18.34% |
| Owned by Institutions (%) | 12.16% |
| Float | 10.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.17 |
| PB Ratio | 1.32 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.82 |
| EV / Sales | 7.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.09 |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.79.
| Current Ratio | 3.36 |
| Quick Ratio | 2.53 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -48.95 |
Financial Efficiency
Return on equity (ROE) is -16.68% and return on invested capital (ROIC) is -11.08%.
| Return on Equity (ROE) | -16.68% |
| Return on Assets (ROA) | -9.67% |
| Return on Capital (ROIC) | -11.08% |
| Revenue Per Employee | 1.99M |
| Profits Per Employee | -2.68M |
| Employee Count | 355 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 0.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.11% in the last 52 weeks. The beta is 0.58, so Arctic Bioscience AS's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +42.11% |
| 50-Day Moving Average | 11.30 |
| 200-Day Moving Average | 10.09 |
| Relative Strength Index (RSI) | 58.48 |
| Average Volume (20 Days) | 11,365 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Arctic Bioscience AS had revenue of NOK 33.76 million and -45.51 million in losses. Loss per share was -1.79.
| Revenue | 33.76M |
| Gross Profit | 9.78M |
| Operating Income | -48.59M |
| Pretax Income | -45.51M |
| Net Income | -45.51M |
| EBITDA | -45.79M |
| EBIT | -48.59M |
| Loss Per Share | -1.79 |
Balance Sheet
The company has 79.60 million in cash and 2.05 million in debt, giving a net cash position of 77.55 million or 3.06 per share.
| Cash & Cash Equivalents | 79.60M |
| Total Debt | 2.05M |
| Net Cash | 77.55M |
| Net Cash Per Share | 3.06 |
| Equity (Book Value) | 258.56M |
| Book Value Per Share | 10.19 |
| Working Capital | 93.51M |
Cash Flow
In the last 12 months, operating cash flow was -40.29 million and capital expenditures -45.33 million, giving a free cash flow of -85.62 million.
| Operating Cash Flow | -40.29M |
| Capital Expenditures | -45.33M |
| Free Cash Flow | -85.62M |
| FCF Per Share | -3.37 |
Margins
Gross margin is 28.97%, with operating and profit margins of -143.93% and -134.84%.
| Gross Margin | 28.97% |
| Operating Margin | -143.93% |
| Pretax Margin | -134.84% |
| Profit Margin | -134.84% |
| EBITDA Margin | -135.66% |
| EBIT Margin | -143.93% |
| FCF Margin | -253.65% |
Dividends & Yields
Arctic Bioscience AS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.88% |
| Shareholder Yield | -3.88% |
| Earnings Yield | -13.26% |
| FCF Yield | -25.00% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |